HEADER HYDROLASE 09-JUL-07 2QJW TITLE CRYSTAL STRUCTURE OF A PUTATIVE HYDROLASE OF THE ALPHA/BETA TITLE 2 SUPERFAMILY (XCC1541) FROM XANTHOMONAS CAMPESTRIS PV. CAMPESTRIS AT TITLE 3 1.35 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: UNCHARACTERIZED PROTEIN XCC1541; COMPND 3 CHAIN: A, B, C, D; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: XANTHOMONAS CAMPESTRIS PV. CAMPESTRIS; SOURCE 3 ORGANISM_TAXID: 340; SOURCE 4 STRAIN: NCPPB 528, LMG 568; SOURCE 5 ATCC: 33913; SOURCE 6 GENE: NP_636912.1, XCC1541; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS PUTATIVE HYDROLASE OF THE ALPHA/BETA SUPERFAMILY, STRUCTURAL KEYWDS 2 GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN KEYWDS 3 STRUCTURE INITIATIVE, PSI-2, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 24-JUL-19 2QJW 1 REMARK LINK REVDAT 5 25-OCT-17 2QJW 1 REMARK REVDAT 4 18-OCT-17 2QJW 1 REMARK REVDAT 3 28-JUL-10 2QJW 1 HEADER TITLE KEYWDS REVDAT 2 24-FEB-09 2QJW 1 VERSN REVDAT 1 24-JUL-07 2QJW 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF UNCHARACTERIZED PROTEIN XCC1541 JRNL TITL 2 (NP_636912.1) FROM XANTHOMONAS CAMPESTRIS AT 1.35 A JRNL TITL 3 RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.78 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 140130 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.216 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 7030 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.35 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.38 REMARK 3 REFLECTION IN BIN (WORKING SET) : 9712 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.60 REMARK 3 BIN R VALUE (WORKING SET) : 0.3370 REMARK 3 BIN FREE R VALUE SET COUNT : 534 REMARK 3 BIN FREE R VALUE : 0.3680 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5138 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 767 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.98 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.80000 REMARK 3 B22 (A**2) : 0.47000 REMARK 3 B33 (A**2) : 0.37000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.26000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.060 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.064 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.048 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.211 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.968 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5564 ; 0.018 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 3709 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7605 ; 1.767 ; 1.976 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9049 ; 1.124 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 748 ; 4.251 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 209 ;26.402 ;22.440 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 859 ;11.019 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 49 ;16.900 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 881 ; 0.075 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6378 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1116 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1266 ; 0.221 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 4240 ; 0.193 ; 0.300 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2805 ; 0.175 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): 2926 ; 0.092 ; 0.500 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 967 ; 0.183 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 25 ; 0.115 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): 124 ; 0.283 ; 0.300 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 78 ; 0.224 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3716 ; 1.906 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1460 ; 0.926 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5817 ; 2.615 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2039 ; 3.989 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1788 ; 5.570 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B C D REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 3 A 175 5 REMARK 3 1 B 3 B 175 5 REMARK 3 1 C 3 C 175 5 REMARK 3 1 D 3 D 175 5 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 908 ; 0.270 ; 0.500 REMARK 3 MEDIUM POSITIONAL 1 B (A): 908 ; 0.290 ; 0.500 REMARK 3 MEDIUM POSITIONAL 1 C (A): 908 ; 0.220 ; 0.500 REMARK 3 MEDIUM POSITIONAL 1 D (A): 908 ; 0.210 ; 0.500 REMARK 3 LOOSE POSITIONAL 1 A (A): 911 ; 0.460 ; 5.000 REMARK 3 LOOSE POSITIONAL 1 B (A): 911 ; 0.490 ; 5.000 REMARK 3 LOOSE POSITIONAL 1 C (A): 911 ; 0.450 ; 5.000 REMARK 3 LOOSE POSITIONAL 1 D (A): 911 ; 0.370 ; 5.000 REMARK 3 MEDIUM THERMAL 1 A (A**2): 908 ; 1.840 ; 2.000 REMARK 3 MEDIUM THERMAL 1 B (A**2): 908 ; 1.350 ; 2.000 REMARK 3 MEDIUM THERMAL 1 C (A**2): 908 ; 1.650 ; 2.000 REMARK 3 MEDIUM THERMAL 1 D (A**2): 908 ; 1.850 ; 2.000 REMARK 3 LOOSE THERMAL 1 A (A**2): 911 ; 2.410 ;10.000 REMARK 3 LOOSE THERMAL 1 B (A**2): 911 ; 1.920 ;10.000 REMARK 3 LOOSE THERMAL 1 C (A**2): 911 ; 2.180 ;10.000 REMARK 3 LOOSE THERMAL 1 D (A**2): 911 ; 2.310 ;10.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE REMARK 3 SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 TO ACCOUNT REMARK 3 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. REMARK 3 3. CHLORIDE IONS, TARTRATE ION AND THE FRAGMENTS OF REMARK 3 POLYETHYLENE GLYCOL 400 MOLECULE WITH DIFFERENT MOLECULAR WEIGHT REMARK 3 WERE MODELED IN THIS STRUCTURE. REMARK 3 4. RESIDUES 71 TO 75 IN SUBUNIT D ARE DISORDERED AND NOT MODELED REMARK 3 IN THE STRUCTURE. REMARK 3 5. UNEXPLAINED ELECTRON DENSITY NEAR RESIDUES A147 AND D147 ARE REMARK 3 NOT MODELED. THEY ARE SUGGESTED AS NITROBENZENE (NBZ). REMARK 4 REMARK 4 2QJW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-JUL-07. REMARK 100 THE DEPOSITION ID IS D_1000043690. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-JUN-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837, 0.97920 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 (HORIZONTAL FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 140150 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.350 REMARK 200 RESOLUTION RANGE LOW (A) : 29.775 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.7600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.35 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.50800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 0.264M DI-AMMONIUM TARTRATE, REMARK 280 15.8% PEG 3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.32000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF FOUR CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 300 SIZE EXCLUSION CHROMATOGRAPHY WITH STATIC LIGHT REMARK 300 SCATTERING SUPPORTS THE ASSIGNMENT OF A DIMER AS A REMARK 300 SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -67.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2760 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY C 0 REMARK 465 MSE C 1 REMARK 465 SER C 2 REMARK 465 GLY D 0 REMARK 465 LYS D 72 REMARK 465 GLY D 73 REMARK 465 PRO D 74 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 19 CG CD1 CD2 REMARK 470 GLU A 26 CD OE1 OE2 REMARK 470 ARG A 30 NE CZ NH1 NH2 REMARK 470 ARG A 47 CD NE CZ NH1 NH2 REMARK 470 ARG A 56 CD NE CZ NH1 NH2 REMARK 470 LYS A 72 CE NZ REMARK 470 GLN A 162 CG CD OE1 NE2 REMARK 470 ARG B 47 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 51 CG CD OE1 NE2 REMARK 470 GLU B 64 CD OE1 OE2 REMARK 470 LYS B 72 CG CD CE NZ REMARK 470 GLN B 162 CG CD OE1 NE2 REMARK 470 ARG B 166 NE CZ NH1 NH2 REMARK 470 ARG C 3 CD NE CZ NH1 NH2 REMARK 470 GLU C 26 CG CD OE1 OE2 REMARK 470 ARG C 47 CD NE CZ NH1 NH2 REMARK 470 LYS C 72 CE NZ REMARK 470 LYS C 107 NZ REMARK 470 GLU C 130 OE1 OE2 REMARK 470 ARG C 156 CD NE CZ NH1 NH2 REMARK 470 GLN C 162 CD OE1 NE2 REMARK 470 ARG C 166 NE CZ NH1 NH2 REMARK 470 GLN C 173 CD OE1 NE2 REMARK 470 ARG D 47 CD NE CZ NH1 NH2 REMARK 470 GLN D 51 CG CD OE1 NE2 REMARK 470 ARG D 56 CZ NH1 NH2 REMARK 470 GLU D 71 CG CD OE1 OE2 REMARK 470 ARG D 97 NE CZ NH1 NH2 REMARK 470 GLU D 130 CD OE1 OE2 REMARK 470 ARG D 166 NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MSE B 108 CG MSE B 108 SE -0.222 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 54 CB - CG - OD2 ANGL. DEV. = -6.2 DEGREES REMARK 500 ARG B 147 NE - CZ - NH1 ANGL. DEV. = -3.9 DEGREES REMARK 500 ARG B 147 NE - CZ - NH2 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG C 144 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG C 144 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 ARG D 147 NE - CZ - NH2 ANGL. DEV. = -4.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 14 -149.71 -102.96 REMARK 500 SER A 81 -119.39 52.63 REMARK 500 VAL A 103 59.95 37.46 REMARK 500 MSE A 108 56.20 -144.10 REMARK 500 MSE A 108 43.87 -141.12 REMARK 500 GLU B 13 -7.23 67.08 REMARK 500 SER B 81 -123.85 56.79 REMARK 500 VAL B 103 64.37 33.98 REMARK 500 MSE B 108 48.09 -148.75 REMARK 500 GLU C 13 -8.39 67.85 REMARK 500 SER C 81 -115.75 54.56 REMARK 500 VAL C 103 60.39 34.70 REMARK 500 GLU D 13 -10.78 68.99 REMARK 500 SER D 81 -116.73 54.69 REMARK 500 SER D 81 -116.73 52.16 REMARK 500 VAL D 103 63.08 33.03 REMARK 500 MSE D 108 46.50 -146.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 176 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 177 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 176 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 178 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 177 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL C 176 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 178 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL C 177 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TLA B 179 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P6G C 178 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG C 179 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 180 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG C 180 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG D 176 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 372467 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE REMARK 999 LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 2QJW A 1 175 UNP Q8PAE4 Q8PAE4_XANCP 1 175 DBREF 2QJW B 1 175 UNP Q8PAE4 Q8PAE4_XANCP 1 175 DBREF 2QJW C 1 175 UNP Q8PAE4 Q8PAE4_XANCP 1 175 DBREF 2QJW D 1 175 UNP Q8PAE4 Q8PAE4_XANCP 1 175 SEQADV 2QJW GLY A 0 UNP Q8PAE4 LEADER SEQUENCE SEQADV 2QJW MSE A 1 UNP Q8PAE4 MET 1 MODIFIED RESIDUE SEQADV 2QJW MSE A 102 UNP Q8PAE4 MET 102 MODIFIED RESIDUE SEQADV 2QJW MSE A 108 UNP Q8PAE4 MET 108 MODIFIED RESIDUE SEQADV 2QJW GLY B 0 UNP Q8PAE4 LEADER SEQUENCE SEQADV 2QJW MSE B 1 UNP Q8PAE4 MET 1 MODIFIED RESIDUE SEQADV 2QJW MSE B 102 UNP Q8PAE4 MET 102 MODIFIED RESIDUE SEQADV 2QJW MSE B 108 UNP Q8PAE4 MET 108 MODIFIED RESIDUE SEQADV 2QJW GLY C 0 UNP Q8PAE4 LEADER SEQUENCE SEQADV 2QJW MSE C 1 UNP Q8PAE4 MET 1 MODIFIED RESIDUE SEQADV 2QJW MSE C 102 UNP Q8PAE4 MET 102 MODIFIED RESIDUE SEQADV 2QJW MSE C 108 UNP Q8PAE4 MET 108 MODIFIED RESIDUE SEQADV 2QJW GLY D 0 UNP Q8PAE4 LEADER SEQUENCE SEQADV 2QJW MSE D 1 UNP Q8PAE4 MET 1 MODIFIED RESIDUE SEQADV 2QJW MSE D 102 UNP Q8PAE4 MET 102 MODIFIED RESIDUE SEQADV 2QJW MSE D 108 UNP Q8PAE4 MET 108 MODIFIED RESIDUE SEQRES 1 A 176 GLY MSE SER ARG GLY HIS CYS ILE LEU ALA HIS GLY PHE SEQRES 2 A 176 GLU SER GLY PRO ASP ALA LEU LYS VAL THR ALA LEU ALA SEQRES 3 A 176 GLU VAL ALA GLU ARG LEU GLY TRP THR HIS GLU ARG PRO SEQRES 4 A 176 ASP PHE THR ASP LEU ASP ALA ARG ARG ASP LEU GLY GLN SEQRES 5 A 176 LEU GLY ASP VAL ARG GLY ARG LEU GLN ARG LEU LEU GLU SEQRES 6 A 176 ILE ALA ARG ALA ALA THR GLU LYS GLY PRO VAL VAL LEU SEQRES 7 A 176 ALA GLY SER SER LEU GLY SER TYR ILE ALA ALA GLN VAL SEQRES 8 A 176 SER LEU GLN VAL PRO THR ARG ALA LEU PHE LEU MSE VAL SEQRES 9 A 176 PRO PRO THR LYS MSE GLY PRO LEU PRO ALA LEU ASP ALA SEQRES 10 A 176 ALA ALA VAL PRO ILE SER ILE VAL HIS ALA TRP HIS ASP SEQRES 11 A 176 GLU LEU ILE PRO ALA ALA ASP VAL ILE ALA TRP ALA GLN SEQRES 12 A 176 ALA ARG SER ALA ARG LEU LEU LEU VAL ASP ASP GLY HIS SEQRES 13 A 176 ARG LEU GLY ALA HIS VAL GLN ALA ALA SER ARG ALA PHE SEQRES 14 A 176 ALA GLU LEU LEU GLN SER LEU SEQRES 1 B 176 GLY MSE SER ARG GLY HIS CYS ILE LEU ALA HIS GLY PHE SEQRES 2 B 176 GLU SER GLY PRO ASP ALA LEU LYS VAL THR ALA LEU ALA SEQRES 3 B 176 GLU VAL ALA GLU ARG LEU GLY TRP THR HIS GLU ARG PRO SEQRES 4 B 176 ASP PHE THR ASP LEU ASP ALA ARG ARG ASP LEU GLY GLN SEQRES 5 B 176 LEU GLY ASP VAL ARG GLY ARG LEU GLN ARG LEU LEU GLU SEQRES 6 B 176 ILE ALA ARG ALA ALA THR GLU LYS GLY PRO VAL VAL LEU SEQRES 7 B 176 ALA GLY SER SER LEU GLY SER TYR ILE ALA ALA GLN VAL SEQRES 8 B 176 SER LEU GLN VAL PRO THR ARG ALA LEU PHE LEU MSE VAL SEQRES 9 B 176 PRO PRO THR LYS MSE GLY PRO LEU PRO ALA LEU ASP ALA SEQRES 10 B 176 ALA ALA VAL PRO ILE SER ILE VAL HIS ALA TRP HIS ASP SEQRES 11 B 176 GLU LEU ILE PRO ALA ALA ASP VAL ILE ALA TRP ALA GLN SEQRES 12 B 176 ALA ARG SER ALA ARG LEU LEU LEU VAL ASP ASP GLY HIS SEQRES 13 B 176 ARG LEU GLY ALA HIS VAL GLN ALA ALA SER ARG ALA PHE SEQRES 14 B 176 ALA GLU LEU LEU GLN SER LEU SEQRES 1 C 176 GLY MSE SER ARG GLY HIS CYS ILE LEU ALA HIS GLY PHE SEQRES 2 C 176 GLU SER GLY PRO ASP ALA LEU LYS VAL THR ALA LEU ALA SEQRES 3 C 176 GLU VAL ALA GLU ARG LEU GLY TRP THR HIS GLU ARG PRO SEQRES 4 C 176 ASP PHE THR ASP LEU ASP ALA ARG ARG ASP LEU GLY GLN SEQRES 5 C 176 LEU GLY ASP VAL ARG GLY ARG LEU GLN ARG LEU LEU GLU SEQRES 6 C 176 ILE ALA ARG ALA ALA THR GLU LYS GLY PRO VAL VAL LEU SEQRES 7 C 176 ALA GLY SER SER LEU GLY SER TYR ILE ALA ALA GLN VAL SEQRES 8 C 176 SER LEU GLN VAL PRO THR ARG ALA LEU PHE LEU MSE VAL SEQRES 9 C 176 PRO PRO THR LYS MSE GLY PRO LEU PRO ALA LEU ASP ALA SEQRES 10 C 176 ALA ALA VAL PRO ILE SER ILE VAL HIS ALA TRP HIS ASP SEQRES 11 C 176 GLU LEU ILE PRO ALA ALA ASP VAL ILE ALA TRP ALA GLN SEQRES 12 C 176 ALA ARG SER ALA ARG LEU LEU LEU VAL ASP ASP GLY HIS SEQRES 13 C 176 ARG LEU GLY ALA HIS VAL GLN ALA ALA SER ARG ALA PHE SEQRES 14 C 176 ALA GLU LEU LEU GLN SER LEU SEQRES 1 D 176 GLY MSE SER ARG GLY HIS CYS ILE LEU ALA HIS GLY PHE SEQRES 2 D 176 GLU SER GLY PRO ASP ALA LEU LYS VAL THR ALA LEU ALA SEQRES 3 D 176 GLU VAL ALA GLU ARG LEU GLY TRP THR HIS GLU ARG PRO SEQRES 4 D 176 ASP PHE THR ASP LEU ASP ALA ARG ARG ASP LEU GLY GLN SEQRES 5 D 176 LEU GLY ASP VAL ARG GLY ARG LEU GLN ARG LEU LEU GLU SEQRES 6 D 176 ILE ALA ARG ALA ALA THR GLU LYS GLY PRO VAL VAL LEU SEQRES 7 D 176 ALA GLY SER SER LEU GLY SER TYR ILE ALA ALA GLN VAL SEQRES 8 D 176 SER LEU GLN VAL PRO THR ARG ALA LEU PHE LEU MSE VAL SEQRES 9 D 176 PRO PRO THR LYS MSE GLY PRO LEU PRO ALA LEU ASP ALA SEQRES 10 D 176 ALA ALA VAL PRO ILE SER ILE VAL HIS ALA TRP HIS ASP SEQRES 11 D 176 GLU LEU ILE PRO ALA ALA ASP VAL ILE ALA TRP ALA GLN SEQRES 12 D 176 ALA ARG SER ALA ARG LEU LEU LEU VAL ASP ASP GLY HIS SEQRES 13 D 176 ARG LEU GLY ALA HIS VAL GLN ALA ALA SER ARG ALA PHE SEQRES 14 D 176 ALA GLU LEU LEU GLN SER LEU MODRES 2QJW MSE A 1 MET SELENOMETHIONINE MODRES 2QJW MSE A 102 MET SELENOMETHIONINE MODRES 2QJW MSE A 108 MET SELENOMETHIONINE MODRES 2QJW MSE B 1 MET SELENOMETHIONINE MODRES 2QJW MSE B 102 MET SELENOMETHIONINE MODRES 2QJW MSE B 108 MET SELENOMETHIONINE MODRES 2QJW MSE C 102 MET SELENOMETHIONINE MODRES 2QJW MSE C 108 MET SELENOMETHIONINE MODRES 2QJW MSE D 1 MET SELENOMETHIONINE MODRES 2QJW MSE D 102 MET SELENOMETHIONINE MODRES 2QJW MSE D 108 MET SELENOMETHIONINE HET MSE A 1 16 HET MSE A 102 8 HET MSE A 108 16 HET MSE B 1 16 HET MSE B 102 8 HET MSE B 108 16 HET MSE C 102 8 HET MSE C 108 16 HET MSE D 1 8 HET MSE D 102 8 HET MSE D 108 16 HET CL A 176 1 HET CL A 177 1 HET CL A 178 1 HET CL B 176 1 HET CL B 177 1 HET CL B 178 1 HET TLA B 179 10 HET PEG B 180 7 HET CL C 176 1 HET CL C 177 1 HET P6G C 178 19 HET PEG C 179 7 HET PEG C 180 7 HET PEG D 176 7 HETNAM MSE SELENOMETHIONINE HETNAM CL CHLORIDE ION HETNAM TLA L(+)-TARTARIC ACID HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM P6G HEXAETHYLENE GLYCOL HETSYN P6G POLYETHYLENE GLYCOL PEG400 FORMUL 1 MSE 11(C5 H11 N O2 SE) FORMUL 5 CL 8(CL 1-) FORMUL 11 TLA C4 H6 O6 FORMUL 12 PEG 4(C4 H10 O3) FORMUL 15 P6G C12 H26 O7 FORMUL 19 HOH *767(H2 O) HELIX 1 1 ALA A 18 LEU A 31 1 14 HELIX 2 2 PHE A 40 ALA A 45 1 6 HELIX 3 3 ARG A 46 GLY A 50 5 5 HELIX 4 4 ASP A 54 GLU A 71 1 18 HELIX 5 5 SER A 81 LEU A 92 1 12 HELIX 6 6 PRO A 133 SER A 145 1 13 HELIX 7 7 HIS A 160 SER A 174 1 15 HELIX 8 8 ALA B 18 GLY B 32 1 15 HELIX 9 9 PHE B 40 ALA B 45 1 6 HELIX 10 10 ARG B 46 GLY B 50 5 5 HELIX 11 11 ASP B 54 THR B 70 1 17 HELIX 12 12 GLU B 71 GLY B 73 5 3 HELIX 13 13 SER B 81 LEU B 92 1 12 HELIX 14 14 PRO B 133 ARG B 144 1 12 HELIX 15 15 HIS B 160 SER B 174 1 15 HELIX 16 16 ALA C 18 LEU C 31 1 14 HELIX 17 17 PHE C 40 ALA C 45 1 6 HELIX 18 18 ARG C 46 GLY C 50 5 5 HELIX 19 19 ASP C 54 GLU C 71 1 18 HELIX 20 20 SER C 81 SER C 91 1 11 HELIX 21 21 PRO C 133 ARG C 144 1 12 HELIX 22 22 HIS C 160 SER C 174 1 15 HELIX 23 23 ALA D 18 GLY D 32 1 15 HELIX 24 24 PHE D 40 ALA D 45 1 6 HELIX 25 25 ARG D 46 GLY D 50 5 5 HELIX 26 26 ASP D 54 THR D 70 1 17 HELIX 27 27 SER D 81 LEU D 92 1 12 HELIX 28 28 PRO D 133 ARG D 144 1 12 HELIX 29 29 HIS D 160 LEU D 175 1 16 SHEET 1 A12 THR A 34 GLU A 36 0 SHEET 2 A12 HIS A 5 ALA A 9 1 N CYS A 6 O THR A 34 SHEET 3 A12 VAL A 75 SER A 80 1 O ALA A 78 N ALA A 9 SHEET 4 A12 ALA A 98 MSE A 102 1 O PHE A 100 N LEU A 77 SHEET 5 A12 ILE A 121 ALA A 126 1 O SER A 122 N LEU A 101 SHEET 6 A12 ARG A 147 VAL A 151 1 O LEU A 149 N HIS A 125 SHEET 7 A12 ARG B 147 VAL B 151 -1 O LEU B 148 N LEU A 150 SHEET 8 A12 ILE B 121 ALA B 126 1 N HIS B 125 O LEU B 149 SHEET 9 A12 THR B 96 MSE B 102 1 N LEU B 101 O SER B 122 SHEET 10 A12 VAL B 75 SER B 80 1 N VAL B 75 O ARG B 97 SHEET 11 A12 HIS B 5 ALA B 9 1 N ALA B 9 O ALA B 78 SHEET 12 A12 THR B 34 GLU B 36 1 O GLU B 36 N LEU B 8 SHEET 1 B12 THR C 34 GLU C 36 0 SHEET 2 B12 HIS C 5 ALA C 9 1 N LEU C 8 O GLU C 36 SHEET 3 B12 VAL C 75 SER C 80 1 O ALA C 78 N ALA C 9 SHEET 4 B12 ALA C 98 MSE C 102 1 O MSE C 102 N GLY C 79 SHEET 5 B12 ILE C 121 ALA C 126 1 O SER C 122 N LEU C 101 SHEET 6 B12 ARG C 147 VAL C 151 1 O LEU C 149 N HIS C 125 SHEET 7 B12 ARG D 147 VAL D 151 -1 O LEU D 148 N LEU C 150 SHEET 8 B12 ILE D 121 ALA D 126 1 N HIS D 125 O LEU D 149 SHEET 9 B12 ALA D 98 MSE D 102 1 N LEU D 101 O SER D 122 SHEET 10 B12 VAL D 76 SER D 80 1 N GLY D 79 O MSE D 102 SHEET 11 B12 HIS D 5 ALA D 9 1 N ALA D 9 O ALA D 78 SHEET 12 B12 THR D 34 GLU D 36 1 O GLU D 36 N LEU D 8 LINK C GLY A 0 N AMSE A 1 1555 1555 1.33 LINK C GLY A 0 N BMSE A 1 1555 1555 1.34 LINK C AMSE A 1 N SER A 2 1555 1555 1.34 LINK C BMSE A 1 N SER A 2 1555 1555 1.34 LINK C LEU A 101 N MSE A 102 1555 1555 1.33 LINK C MSE A 102 N VAL A 103 1555 1555 1.33 LINK C LYS A 107 N AMSE A 108 1555 1555 1.33 LINK C LYS A 107 N BMSE A 108 1555 1555 1.33 LINK C AMSE A 108 N GLY A 109 1555 1555 1.34 LINK C BMSE A 108 N GLY A 109 1555 1555 1.32 LINK C GLY B 0 N AMSE B 1 1555 1555 1.33 LINK C GLY B 0 N BMSE B 1 1555 1555 1.31 LINK C AMSE B 1 N SER B 2 1555 1555 1.32 LINK C BMSE B 1 N SER B 2 1555 1555 1.33 LINK C LEU B 101 N MSE B 102 1555 1555 1.32 LINK C MSE B 102 N VAL B 103 1555 1555 1.35 LINK C LYS B 107 N AMSE B 108 1555 1555 1.33 LINK C LYS B 107 N BMSE B 108 1555 1555 1.34 LINK C BMSE B 108 N GLY B 109 1555 1555 1.33 LINK C AMSE B 108 N GLY B 109 1555 1555 1.34 LINK C LEU C 101 N MSE C 102 1555 1555 1.32 LINK C MSE C 102 N VAL C 103 1555 1555 1.32 LINK C LYS C 107 N BMSE C 108 1555 1555 1.34 LINK C LYS C 107 N AMSE C 108 1555 1555 1.34 LINK C BMSE C 108 N GLY C 109 1555 1555 1.32 LINK C AMSE C 108 N GLY C 109 1555 1555 1.32 LINK C MSE D 1 N BSER D 2 1555 1555 1.32 LINK C MSE D 1 N ASER D 2 1555 1555 1.33 LINK C LEU D 101 N MSE D 102 1555 1555 1.32 LINK C MSE D 102 N VAL D 103 1555 1555 1.30 LINK C LYS D 107 N BMSE D 108 1555 1555 1.33 LINK C LYS D 107 N AMSE D 108 1555 1555 1.34 LINK C BMSE D 108 N GLY D 109 1555 1555 1.32 LINK C AMSE D 108 N GLY D 109 1555 1555 1.33 SITE 1 AC1 3 GLY B 11 SER B 14 ALA B 18 SITE 1 AC2 3 ARG B 3 TRP B 33 GLN B 173 SITE 1 AC3 4 HIS A 35 GLU A 36 ARG A 37 HOH A 367 SITE 1 AC4 2 ARG B 47 GLY B 50 SITE 1 AC5 5 ARG A 147 HOH A 184 VAL B 151 ASP B 152 SITE 2 AC5 5 HIS B 160 SITE 1 AC6 5 ARG C 147 HOH C 185 VAL D 151 ASP D 152 SITE 2 AC6 5 HIS D 160 SITE 1 AC7 6 VAL A 151 ASP A 152 HIS A 160 HOH A 352 SITE 2 AC7 6 ARG B 147 HOH B 192 SITE 1 AC8 4 VAL C 151 ASP C 152 ARG D 147 HOH D 189 SITE 1 AC9 14 GLY B 11 PHE B 12 SER B 14 LYS B 20 SITE 2 AC9 14 SER B 81 HIS B 155 ARG B 156 PEG B 180 SITE 3 AC9 14 HOH B 197 HOH B 207 HOH B 222 ARG C 67 SITE 4 AC9 14 GLN C 93 PRO C 95 SITE 1 BC1 5 ASP C 152 ASP C 153 GLY C 154 HOH C 267 SITE 2 BC1 5 HOH C 318 SITE 1 BC2 7 PRO C 120 ILE C 121 ARG C 147 HOH C 186 SITE 2 BC2 7 HOH C 262 HOH C 287 HOH D 249 SITE 1 BC3 3 SER B 81 TLA B 179 HOH B 268 SITE 1 BC4 5 ARG B 3 HOH B 309 LYS C 107 GLY C 109 SITE 2 BC4 5 HOH C 205 SITE 1 BC5 2 ASP D 39 ASP D 42 CRYST1 71.800 60.640 74.720 90.00 94.57 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013928 0.000000 0.001112 0.00000 SCALE2 0.000000 0.016491 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013426 0.00000 MASTER 476 0 25 29 24 0 23 6 0 0 0 56 END